Clinical Trials Logo

Clinical Trial Summary

Oral antithrombotic medications (OAM) are used for the prevention and treatment of thrombotic disorders. Among hemorrhagic complications of OAMs, intracranial hemorrhage (ICH) may have particularly devastating consequences with high morbidity, disability and mortality rates. The efficacy and safety profiles of OAMs are generally assessed in randomized controlled trials (RCT), but included patients are often highly selected and may not be representative of users in everyday clinical practice in terms of follow-up routines, age, gender, drug compliance, and polypharmacy. Moreover, it is often unclear whether or not traumatic ICHs are registered and reported in RCTs. Drifts in indications and treatment criteria may also be seen in everyday practice and drug discontinuation due to precautionary concerns including compliance, fall risk and comorbidity may be forgotten. Collectively, these factors may lead to other and potentially higher traumatic ICH rates in general clinical use than reported in RCTs.

The incidence rates of traumatic ICH in patients on OAMs in the general population remain unknown. In this nationwide registry based pharmacoepidemiological study we will investigate the incidence and case fatality of traumatic ICH in users of OAMs in Norway from 2008 through 2014.

Clinical Trial Description


Study Design

Related Conditions & MeSH terms

NCT number NCT02996851
Study type Observational
Source St. Olavs Hospital
Status Completed
Phase N/A
Start date January 2007
Completion date December 31, 2014

See also
  Status Clinical Trial Phase
Recruiting NCT04304651 - Screening for Occult Malignancy in Patients With Unprovoked Venous Thromboembolism N/A
Completed NCT00216866 - The Catheter Study: Central Venous Catheter Survival in Cancer Patients Using Low Molecular Weight Heparin (Dalteparin) for the Treatment of Deep Vein Thrombosis Phase 2
Completed NCT00670540 - Epidemiology of Thromboembolism Disease: A Cohort Study N/A
Recruiting NCT04263038 - Clinical Surveillance vs. Anticoagulation for Low-risk Patients With Isolated Subsegmental Pulmonary Embolism Phase 4
Recruiting NCT04388657 - COVID-19, bLOod Coagulation and Thrombosis
Recruiting NCT04439383 - Risk Stratification for Venous Thromboembolism in Hospitalized Medical Patients
Completed NCT01897103 - Platelet Activity in Vascular Surgery for Thrombosis and Bleeding N/A
Completed NCT02720328 - Prevalence and Causes of Preventable and Serious Adverse Drug Reactions Related to the Use of Oral Anticoagulants Phase 4
Completed NCT01203098 - A Phase 2b Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Hip Arthroplasty Phase 2
Completed NCT00830570 - The Clinical and Economic Impact of Pharmacogenomic Testing of Warfarin Therapy in Typical Community Practice Settings N/A
Completed NCT01086215 - Registry of AngioJet Use in the Peripheral Vascular System N/A
Completed NCT00119457 - Factor IX Inhibition in Thrombosis Prevention (The FIXIT Trial) Phase 2
Terminated NCT02610608 - Medical Assistance for the Procreation and Risk of Thrombosis.
Completed NCT04368377 - Enhanced Platelet Inhibition in Critically Ill Patients With COVID-19 Phase 2
Completed NCT02376777 - Comparison of Accidents and Their Circumstances With Oral Anticoagulants N/A
Recruiting NCT04375982 - Evaluation of the LumiraDx Point of Care D-Dimer and CRP Tests N/A